期刊
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
卷 100, 期 24, 页码 10563-10572出版社
SPRINGER
DOI: 10.1007/s00253-016-7873-1
关键词
Oxytetracycline; Biosynthetic gene cluster; Heterologous expression; Metabolic engineering; Streptomyces venezuelae; Fermentation process
资金
- Shengxue Dacheng Pharmaceutical Co., Ltd.
- National Natural Science Foundation of China [31400034, 31570031]
- Ministry of Science and Technology of China [2013CB734001]
- Youth Innovation Promotion Association of CAS [92016087]
Heterologous expression is an important strategy to activate biosynthetic gene clusters of secondary metabolites. Here, it is employed to activate and manipulate the oxytetracycline (OTC) gene cluster and to alter OTC fermentation process. To achieve these goals, a fast-growing heterologous host Streptomyces venezuelae WVR2006 was rationally selected among several potential hosts. It shows rapid and dispersed growth and intrinsic high resistance to OTC. By manipulating the expression of two cluster-situated regulators (CSR) OtcR and OtrR and precursor supply, the OTC production level was significantly increased in this heterologous host from 75 to 431 mg/l only in 48 h, a level comparable to the native producer Streptomyces rimosus M4018 in 8 days. This work shows that S. venezuelae WVR2006 is a promising chassis for the production of secondary metabolites, and the engineered heterologous OTC producer has the potential to completely alter the fermentation process of OTC production.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据